Macitentan and Tadalafil Combination Shows Sustained Efficacy in PAH In a recent study, long-term combination therapy with macitentan and tadalafil demonstrated favorable tolerability and sustained efficacy in patients with PAH.

Long-term treatment with a single-tablet fixed-dose combination of #Macitentan and #Tadalafil is well tolerated and maintains efficacy over 2 years in patients with pulmonary arterial hypertension (#PAH).

Read more: https://bit.ly/3NJTUWA

#RareDisease #MedSky #PulmonaryArterialHypertension

A new observational study using INSPECTIO supports the effectiveness of guideline-directed therapy and regular risk assessment to optimize treatment strategies in Pulmonary Arterial Hypertension.
#PAH #ClinicalResearch #INSPECTIO #ObservationalStudy #Macitentan #Selexipag
doi.org/10.1016/j.vp...